HMG-COA reductase inhibitors (statins) increase the expression of COX-2 in gallbladder epithelial cells

被引:0
|
作者
Choi, Min Ho [1 ]
机构
[1] Hallym Univ, Chunchon, South Korea
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A33 / A33
页数:1
相关论文
共 50 条
  • [41] HMG-CoA Reductase Inhibitors (Statins) Characterized as Direct Inhibitors of P-Glycoprotein
    Er-jia Wang
    Christopher N. Casciano
    Robert P. Clement
    William W. Johnson
    Pharmaceutical Research, 2001, 18 : 800 - 806
  • [42] The rationale for using HMG-CoA reductase inhibitors ('statins') in peripheral arterial disease
    Erez, G.
    Leitersdorf, E.
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2007, 33 (02) : 192 - 201
  • [43] Current data with HMG-CoA reductase inhibitors (statins) for colorectal cancer prevention
    Tyagi, Preeta
    Chu, Edward
    Nadler, Eric
    Jain, Vinay K.
    CLINICAL COLORECTAL CANCER, 2005, 5 (04) : 245 - 246
  • [44] Effects of HMG-CoA Reductase Inhibitors on Skeletal MuscleAre all Statins the Same?
    Marc Evans
    Alan Rees
    Drug Safety, 2002, 25 : 649 - 663
  • [45] Effects of HMG-CoA reductase inhibitors on skeletal muscle - Are all statins the same?
    Evans, M
    Rees, A
    DRUG SAFETY, 2002, 25 (09) : 649 - 663
  • [46] HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway
    Dimmeler, S
    Aicher, A
    Vasa, M
    Mildner-Rihm, C
    Adler, K
    Tiemann, M
    Rütten, H
    Fichtlscherer, S
    Martin, H
    Zeiher, AM
    JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (03): : 391 - 397
  • [47] Lipophilic HMG-CoA reductase inhibitors increase myocardial stunning in dogs
    Satoh, K
    Ichihara, K
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 35 (02) : 256 - 262
  • [48] Predictive Modeling of HMG-CoA Reductase Inhibitory Activity and Design of New HMG-CoA Reductase Inhibitors
    Samizo, Shigeyoshi
    Kaneko, Hiromasa
    ACS OMEGA, 2023, 8 (30): : 27247 - 27255
  • [49] HMG-CoA reductase inhibitors: Role in normal and malignant cells
    Larsson, O
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 1996, 22 (03) : 197 - 212
  • [50] HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients
    Chung, YS
    Lee, MD
    Lee, SK
    Kim, HM
    Fitzpatrick, LA
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (03): : 1137 - 1142